Page last updated: 2024-10-31

metyrapone and Vomiting

metyrapone has been researched along with Vomiting in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sam, TS1
Kan, KK1
Ngan, MP1
Rudd, JA1
Yeung, JH1
Rose, SR1
Lustig, RH1
Burstein, S1
Pitukcheewanont, P1
Broome, DC1
Burghen, GA1

Other Studies

2 other studies available for metyrapone and Vomiting

ArticleYear
Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
    European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2

    Topics: Acute Disease; Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Cisplatin; Cosyntropin; Fer

2003
Diagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test.
    Hormone research, 1999, Volume: 52, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Child; Child, Preschool; Female; Humans; Hydrocortisone; Hy

1999